Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Pediatric Hematology
•
Iron Homeostasis
•
Primary Care
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
Answer from: at Community Practice
Excellent article on this topic: Baskin-Miller et al., PMID 39096194
Sign in or Register to read more
26026
Related Questions
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
What parameters would you use to monitor and interpret iron levels in a hemochromatosis patient where ferritin is unreliable due to underlying chronic inflammation?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
Does evidence support extending the duration of intravenous iron dextran (INFeD) infusion in pregnant patients?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?